Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00938678
Recruitment Status : Completed
First Posted : July 14, 2009
Last Update Posted : March 20, 2017
Information provided by (Responsible Party):
Hospira, now a wholly owned subsidiary of Pfizer

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2009
  Study Completion Date : October 2009